Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DDX52 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FOXA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEIS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC646484 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
LINC01361 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KIAA0141 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTHLH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01448 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESPNP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD116-21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRN4CL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRGAP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on